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RAUWOLFIA. By R. E. Woodson, Jr., H. W. Youngken, E. Schlittler, and
J. A. Schneider. Boston, Toronto, Little, Brown and Co., 1957. 137 pp.
$5.50.
For research workers who are interested in this important group of alka-
loids, which includes the fascinating drug reserpine, this should prove to be
a useful and compact reference volume because it is an attempt to collate all
pertinent information available (up to about eight months ago) on the sub-
ject. The book is composed of four chapters covering four fields of knowl-
edge on the subject, contributed by well-known authorities: Robert E.
Woodson, Jr., on the botany of Rauwolfia, Heber W. Youngken on the
pharmacognosy of Rauwolfia, Emil Schlittler on its chemistry, and Jurg A.
Schneider on its pharmacology.
The chapter on the chemistry of the alkaloids is somewhat more satis-
fying than that on the pharmacology, because the chemistry is now fairly
well understood and our chemical knowledge about these alkaloids near
complete, having reached its culmination in the synthesis of reserpine by
Woodward's group in 1956. The weakest point in our chemical knowledge,
at least for now, is in the generalizations which may be drawn upon the
relation between chemical constitution and reserpine-like activity. Very
little on this subject appears in this book, and the reason is simply that the
subject has been only superficially explored to date.
Probably the most complex problem tackled in this volume is the pharma-
cology of Rauwolfia. Doctor J. A. Schneider has done a creditable job in
gathering together the most pertinent information and presenting it in a
well-organized fashion. It is clear that he has given a great deal of thought
to the problem and has brought to bear on it his own considerable investiga-
tions in the field. If one were pressed for a criticism of this chapter (and
this is more in the nature of a personal desire than a criticism), one might
say that it would have been interesting to know in what direction Dr.
Schneider leans concerning the mechanism of action of reserpine. On the
other hand, giving such an indication might easily lead to the criticism
which can be made on his willingness to dismiss as minor in reserpine's
mode of action the direct peripheral effects of the drug. It seems to this
reviewer that a delineation of the relative importance of its peripheral
actions must await more definitive investigations in this area.
NICHOLAS J. GIARMAN
LYSERGIC ACID DIETHYLAMIDE AND MESCALINE IN EXPERIMENTAL PsY-
CHIATRY. Louis Cholden, Ed. New York, Grune & Stratton, 1956. 85 pp.
$3.00.
There are exceedingly few-if any-occasions of hunger in which the menu
can suffice for the meal. This menu, a slim volume possibly raised in dignity
and certainly in price by hardbacked and drug-house-backed publication,
represents the Proceedings of the Round Table on LSD and Mescaline held
at the 1955 meetings of the American Psychiatric Association. The gavel-
enforced brevity of such a conclave is further edited for the reader who,
however, might have leisure as well as curiosity. Unhappily, the interested
student will find here neither comprehensive survey and summary nor ade-
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quate bibliography. He will be tersely introduced to some of the salient
issues and eminent researchers concerned with a fascinating era in experi-
mental psychiatry. The earnest research spirit of the editor and contributors
results in a product that, for all its inadequacies, is informative rather than
sensational-a remarkable feat in a climate currently dazzled if not dazed
by drugs.
Neither the effects nor novelty of drugs which alter behavior can account
for contemporary interest; such agents have been long known and fre-
quently studied. In our opinion, what is both new and compelling is con-
tained in the misformulation, "model psychosis." More precisely, what is
new is the formulation of models for psychosis, conceptual models for psy-
chotic behavior which can be tested and proposed from a variety of frames
of reference: biochemical, neurophysiological, and behavioral. The advent
of "blocking agents," such as reserpine, along with the "inducing agents,"
such as LSD, provides the chemist with a familiar biochemical model and
a behavioral system he can manipulate. Several such hypotheses are briefly
reviewed in this volume, and while serotonin theories are shown to be
obviously inadequate, the relevance of a naturally occurring body hormone
to behavior disorder is at last experimentally broached. Similarly, the ex-
citing possibilities in the currently developing area of the catechol amines
are touched upon. While the relation of any brain or biochemical change to
observed and experienced behavior remains (as ever) obscure, develop-
ments in the psychiatric field which parallel the biochemical advances are
reported. Among such topics discussed are problems in the use of LSD in
therapy and improved understanding of management problems on the part
of therapists who took the drug. Neurophysiological techniques and the role
of reticular systems are also sketchily represented here; the research of the
experimental psychologist unfortunately is not.
The descriptions of experimental psychosis are valuable because of their
compactness, but the unusual feature of this introduction to experimental
psychiatry is a viewpoint that questions the implication that drug-induced
hallucinations are necessarily psychotic or unreal. LSD and mescaline do
not compel psychosis in all subjects but may produce visionary experience.
"What reason," one contributor asks, "have we for thinking that beauty
and significance are less real than ugliness or dullness?" He appears in the
list of contributors as "Aldous Huxley, Man of Letters, Los Angeles,
California." DANIEL X. FREEDMAN
THE RAUWOLFIA STORY. FROM PRIMITIVE MEDICINE TO ALKALOIDAL
THERAPY. Summit, New Jersey, Ciba Pharmaceutical Products, Inc., 1954.
63 pp.
The history of the Rauwolfia alkaloids is described in this soft-covered,
pocketsized book. The plant containing the alkaloids was discovered in
India in the seventeenth century by a French botanist who named it
Rauwolfia serpentina after a German physician and explorer, Dr. Leonhard
Rauwolf. It was believed that eating the root relieved man of madness; for
five centuries it had been used in India to treat insanity. Modern Indian
physicians used the root as a sedative and antihypertensive for two decades
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